Mylab, a prominent provider of healthcare and diagnostic solutions, announced a strategic partnership with Ekincare, India's leading corporate wellness and health benefits platform. This collaboration aims to promote NASOVAC-S4, a pioneering influenza nasal vaccine developed by the Serum Institute of India (SII), among corporate entities. The
Labs with small set-up or in remote areas can now run important tests such as Thyroid panel, cardiac marker (Troponin), CRP, D-Dimer and more. Launches MyBox+ device with proprietary Dry Luminescence Immunoassay (LIA) for results in few minutes and faster treatment. Mylab Discovery Solutions, a
Sickle-cell anaemia (SCA), a genetic blood disorder, is a public health challenge as India is estimated to have the second-highest burden of the disease, with around 1.8 crore people with sickle cell traits and 14 lakhs with sickle cell disease. Sickle cell Anemia often causes
Partnership to focus on advanced molecular diagnostic solutions for key health challenges including diabetic foot infection – reducing risk of serious complications Mylab Discovery Solutions, India’s leading biotech company, and DnaNudge, a UK-based pioneer of consumer genetics testing and medical diagnostics, today announced a
Designed to deliver confidence and reliability for diagnostic development and testing, the Applied Biosystems™ TaqPath™ PCR kits for infectious diseases such as Multi-Drug Resistant Tuberculosis (MTB MDR), M. Tuberculosis complex (MTB), Hepatitis B Virus (HBV), Hepatitis C Virus (HCV), Human Immunodeficiency Virus (HIV), and for
It is a highly accurate test and detects all COVID-19 variants in 20 seconds It will be available in international markets later this year Mylab Discovery Solutions, India’s leading biotechnology company, and Portland, OR-based Hemex Health, a medical diagnostic device company focused on creating diagnostics
